BMXMF (BioMerieux) Inventories, Finished Goods: $563 Mil (As of Dec. 2025)


BMXMF BioMerieux SA BMXMF
67 GF Score
Price $82.78
GF Value $127.88
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is BioMerieux Inventories, Finished Goods?

BioMerieux BMXMF 67 Inventories, Finished Goods is $563 Mil as of Dec. 2025. GuruFocus rates BMXMF with a GF Score™ of 67/100 and a GF Value™ of $127.88 (Significantly Undervalued). The stock has 3 warning signs investors should review.

BioMerieux's quarterly finished goods declined from Dec. 2024 ($558 Mil) to Jun. 2025 ($556 Mil) but then increased from Jun. 2025 ($556 Mil) to Dec. 2025 ($563 Mil).

BioMerieux's annual finished goods increased from Dec. 2023 ($488 Mil) to Dec. 2024 ($558 Mil) and increased from Dec. 2024 ($558 Mil) to Dec. 2025 ($563 Mil).

BioMerieux Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for BioMerieux's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioMerieux Inventories, Finished Goods Chart

BioMerieux Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 370.51 365.36 487.79 558.01 563.35

BioMerieux Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 487.79 567.92 558.01 556.29 563.35
BMXMF
67GF Score
BioMerieux SA BMXMF
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioMerieux Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of $563 Mil mean?
BioMerieux (BMXMF) has a Inventories, Finished Goods of $563 Mil as of Dec. 2025. Finished goods are inventory items that are complete and ready to be sold. View historical data on BioMerieux and its competitors.
Is BioMerieux's Inventories, Finished Goods too high?
BioMerieux's current Inventories, Finished Goods is $563 Mil. Overall, BioMerieux has a GF Score™ of 67/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does BioMerieux's Inventories, Finished Goods compare to TMO and DHR?
BioMerieux's Inventories, Finished Goods of $563 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Diagnostics & Research company?
A good Inventories, Finished Goods depends on the Medical Diagnostics & Research industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on BioMerieux and its competitors. BioMerieux's current Inventories, Finished Goods is $563 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioMerieux stock overvalued right now?
Based on GuruFocus' analysis, BioMerieux (BMXMF) is currently considered Significantly Undervalued. The stock's GF Value™ is $127.88, compared to a current price of $82.78 — trading 35.3% below its estimated fair value. The current Inventories, Finished Goods is $563 Mil. BioMerieux's overall GF Score™ is 67/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For BioMerieux (BMXMF), the current Inventories, Finished Goods is $563 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioMerieux (BMXMF) Overvalued in 2026?

Based on GuruFocus' analysis, BioMerieux stock appears to be undervalued. The current stock price of $82.78 is trading 35.3% below its estimated GF Value™ of $127.88. GuruFocus considers BioMerieux to be Significantly Undervalued.

Key valuation signals for BMXMF:

  • Inventories, Finished Goods: $563 Mil
  • GF Value™: $127.88 vs. price of $82.78 (35.3% below fair value)
  • GF Score™: 67/100 with 3 warning signs

No single metric tells the full story. See the BMXMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioMerieux Business Description

Address Marcy l’Etoile, Lyon, FRA, 69280
BioMérieux designs, develops, and manufactures a broad portfolio of in vitro diagnostics for detecting disease-causing pathogens and contamination. The company operates in four segments: molecular biology (42% of 2024 sales), microbiology (33%), immunoassays (10%), and industrial applications (about 15%). The Americas account for the largest portion of the firm's revenue (40%), followed by Asia-Pacific (27%) and Europe, the Middle East, and Africa (27%). BioMérieux is headquartered in Marcy-l'Étoile, France.
67GF Score

Get the complete analysis for BMXMF

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$82.78
Price
$127.88
GF Value